These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2576139)

  • 1. The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat.
    Crisp T; Stafinsky JL; Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1989 Nov; 34(3):497-501. PubMed ID: 2576139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methysergide potentiates the hyperactivity produced by MDMA in rats.
    Gold LH; Koob GF
    Pharmacol Biochem Behav; 1988 Mar; 29(3):645-8. PubMed ID: 2896363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine.
    Nencini P; Woolverton WL; Seiden LS
    Brain Res; 1988 Aug; 457(1):136-42. PubMed ID: 2901895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative profile of MDMA.
    Schechter MD
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1533-7. PubMed ID: 2874566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF; Meltzer HY; Gudelsky GA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
    Spanos LJ; Yamamoto BK
    Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
    Winslow JT; Insel TR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):212-20. PubMed ID: 1973197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Schechter MD
    Pharmacol Biochem Behav; 1988 Dec; 31(4):817-24. PubMed ID: 2908067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
    Gold LH; Hubner CB; Koob GF
    Psychopharmacology (Berl); 1989; 99(1):40-7. PubMed ID: 2571175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
    Schmidt CJ; Black CK; Abbate GM; Taylor VL
    Brain Res; 1990 Oct; 529(1-2):85-90. PubMed ID: 1980848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin receptor antagonists induce hyperalgesia without preventing morphine antinociception.
    Berge OG; Fasmer OB; Hole K
    Pharmacol Biochem Behav; 1983 Nov; 19(5):873-8. PubMed ID: 6647521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychostimulant properties of MDMA.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 95():345-6. PubMed ID: 2577038
    [No Abstract]   [Full Text] [Related]  

  • 14. A local serotonergic component involved in the spinal antinociceptive action of morphine.
    Crisp T; Smith DJ
    Neuropharmacology; 1989 Oct; 28(10):1047-53. PubMed ID: 2554180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
    Callaway CW; Rempel N; Peng RY; Geyer MA
    Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA; Takeda H; Cho AK; Howard SG
    Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats.
    Hiramatsu M; Nabeshima T; Kameyama T; Maeda Y; Cho AK
    Pharmacol Biochem Behav; 1989 Jun; 33(2):343-7. PubMed ID: 2573077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential actions of the blockade of spinal opioid, adrenergic and serotonergic receptors on the tail-flick inhibition induced by morphine microinjected into dorsal raphe and central gray in rats.
    Tseng LL; Tang R
    Neuroscience; 1989; 33(1):93-100. PubMed ID: 2557562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally administered MDMA causes a long-term depletion of serotonin in rat brain.
    Finnegan KT; Ricaurte GA; Ritchie LD; Irwin I; Peroutka SJ; Langston JW
    Brain Res; 1988 Apr; 447(1):141-4. PubMed ID: 2898273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.